417 related articles for article (PubMed ID: 29202439)
1. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.
Antonio M; Maggio RM
J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439
[TBL] [Abstract][Full Text] [Related]
2. Chemometric study of the excipients' influence on polymorphic-behavior. Mefenamic acid as case of study.
Antonio M; Calvo NL; Maggio RM
J Pharm Biomed Anal; 2019 Jun; 170():8-15. PubMed ID: 30901720
[TBL] [Abstract][Full Text] [Related]
3. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
4. Prediction of dissolution profiles by non-destructive NIR spectroscopy in bilayer tablets.
Baranwal Y; Román-Ospino AD; Keyvan G; Ha JM; Hong EP; Muzzio FJ; Ramachandran R
Int J Pharm; 2019 Jun; 565():419-436. PubMed ID: 31085258
[TBL] [Abstract][Full Text] [Related]
5. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
6. Tackling quantitative polymorphic analysis through fixed-dose combination tablets production. Pyrazinamide polymorphic assessment.
Antonio M; Raffaghelli M; Maggio RM
J Pharm Biomed Anal; 2021 Feb; 194():113786. PubMed ID: 33281002
[TBL] [Abstract][Full Text] [Related]
7. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
[TBL] [Abstract][Full Text] [Related]
8. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
Porfire A; Filip C; Tomuta I
J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of mefenamic acid polymorphs by terahertz-chemometrics.
Otsuka M; Nishizawa J; Shibata J; Ito M
J Pharm Sci; 2010 Sep; 99(9):4048-53. PubMed ID: 20665848
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of chemometric approaches for polymorphs quantification in tablets using near-infrared hyperspectral images.
da Silva VH; Soares-Sobrinho JL; Pereira CF; Rinnan Å
Eur J Pharm Biopharm; 2019 Jan; 134():20-28. PubMed ID: 30414499
[TBL] [Abstract][Full Text] [Related]
11. Solid-state characterization of mefenamic acid.
Panchagnula R; Sundaramurthy P; Pillai O; Agrawal S; Raj YA
J Pharm Sci; 2004 Apr; 93(4):1019-29. PubMed ID: 14999737
[TBL] [Abstract][Full Text] [Related]
12. Development of robust quantitative methods by near-infrared spectroscopy for rapid pharmaceutical determination of content uniformity in complex tablet matrix.
Xiang D; Konigsberger M; Wabuyele B; Hornung K; Cheney J
Analyst; 2009 Jul; 134(7):1405-15. PubMed ID: 19562209
[TBL] [Abstract][Full Text] [Related]
13. A process analytical technology approach based on near infrared spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of intact tablets.
Blanco M; Alcalá M; González JM; Torras E
J Pharm Sci; 2006 Oct; 95(10):2137-44. PubMed ID: 16883562
[TBL] [Abstract][Full Text] [Related]
14. Prediction of drug dissolution profiles from tablets using NIR diffuse reflectance spectroscopy: a rapid and nondestructive method.
Freitas MP; Sabadin A; Silva LM; Giannotti FM; do Couto DA; Tonhi E; Medeiros RS; Coco GL; Russo VF; Martins JA
J Pharm Biomed Anal; 2005 Sep; 39(1-2):17-21. PubMed ID: 15935597
[TBL] [Abstract][Full Text] [Related]
15. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of the manufacturing process for ambroxol hydrochloride tablet using NIR-chemometric methods: compression effect on content uniformity model and relevant process parameters testing.
Yang H; Liao X; Peng F; Wang W; Liu Y; Yan J; Li H
Drug Dev Ind Pharm; 2015; 41(11):1877-87. PubMed ID: 25738811
[TBL] [Abstract][Full Text] [Related]
17. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
Otsuka M; Kato F; Matsuda Y; Ozaki Y
AAPS PharmSciTech; 2003; 4(2):E19. PubMed ID: 12916901
[TBL] [Abstract][Full Text] [Related]
18. Use of chemometrics to compare NIR and HPLC for the simultaneous determination of drug levels in fixed-dose combination tablets employed in tuberculosis treatment.
Teixeira KSS; da Cruz Fonseca SG; de Moura LCB; de Moura MLR; Borges MHP; Barbosa EG; De Lima E Moura TFA
J Pharm Biomed Anal; 2018 Feb; 149():557-563. PubMed ID: 29197297
[TBL] [Abstract][Full Text] [Related]
19. Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.
Barakh Ali SF; Rahman Z; Dharani S; Afrooz H; Khan MA
J Pharm Sci; 2019 Mar; 108(3):1211-1219. PubMed ID: 30773201
[TBL] [Abstract][Full Text] [Related]
20. Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls.
Xiang D; Berry J; Buntz S; Gargiulo P; Cheney J; Joshi Y; Wabuyele B; Wu H; Hamed M; Hussain AS; Khan MA
J Pharm Sci; 2009 Mar; 98(3):1155-66. PubMed ID: 18702120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
